‘ChatGPT for Doctors’ Startup OpenEvidence Secures $12B Valuation

OpenEvidence, a medical AI startup, secured $250 million in funding, doubling its valuation to $12 billion. The ad-supported platform, often called "ChatGPT for doctors," is rapidly gaining adoption among U.S. physicians. This milestone reflects growing investment in AI tools designed specifically for healthcare professionals.